Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Van De Wetering, Marianne D ^a   Van Woensel, J B M ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b NONE

Author keywords

*Antibiotic prophylaxis; *Neoplasms therapy ; Catheterization, central venous *adverse effects ; Gram positive bacterial infections *prevention control ; Humans; Randomized controlled trials as topic

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; HEPARIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION PREVENTION; MEDLINE; REVIEW;

EID: 37249067319     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003295.pub2     Document Type: Review

References (38)

1. Barriga 1997 {published data only} Barriga FJ, Varas M, Potin M, Sapunar F, Rojo H, Martinez A, et al.Efficacy of a vancomycin solution to prevent bacteraemia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology 1997;28:196-200.
2. Daghistani 1996 {published data only} Daghistani D, Horn M, Rodriguez Z, Schoenike S, Toledano S. Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology 1996;26:405-8.
3. Henrickson 2000 {published data only} Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al.Prevention of central venous catheter related infections and thrombotic events in immuno compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized multicenter double blind trial. Journal of Clinical Oncology 2000;18(6):1269-78.
4. Lim 1993 {published data only} Lim SH, Smith MP, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal of Haematology 1993;suppl 54:10-3.
5. Ljungman 1997 {published data only} Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized controlled study. Support Care Cancer 1997;5:485-8.
6. Rackoff 1995 {published data only} Rackoff WR, Weiman M, Jakobowski D, Hirschl R, Stallings V, Bilodeau, et al.A randomized controlled trial of the efficacy of a heparin and vancomycin flush solution in preventing central venous catheter infections in children. Journal of Paediatrics 1995;127(1):147-51.
7. Ranson 1990 {published data only} Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. The Journal of Hospital Infection 1990;15:95-102.
8. Schwartz 1990 {published data only} Schwartz C, Henrickson K, Roghmann K, Powell K. Prevention of bacteraemia attributed to luminal colonization of tunneled central venous catheters with vancomycin susceptible organisms. Journal of Clinical Oncology 1990;8(9):1591-7.
9. Vassilomaniakis 1995 {published data only} Vassilomaniakis M, Platniotis G, Koumakis G. Central venous catheter related infections after bone marrow transplantation in patients with malignancies: a prospective study with short course vancomycin prophylaxis. Bone Marrow Transplantation 1995;15:77-80.
10. Al Sibai 1987 Al Sibai MB, Harder EJ, Faskin RW, Johnson GW, Padmos MA. The value of prophylactic antibiotics during the insertion of long-term indwelling silastic right atrial catheters in cancer patients. Cancer 1987;60:1891-5.
11. Carratala 1999 Carratala J, Niubo J, Fernandez-Sevilla A, Juve E, Castellsague X, Berlanga J, et al.Randomized, double-blind trial of an antibiotic-lock technique for prevention of Gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrobial Agents and Chemotherapy 1999;43(9):2200-4.
12. Chatzinikolaou 03a Chatzinikolaou I, Zipf T, Hanna H, Umphrey J, Roberts W, Sheretz R, et al.Minocycline-ethylenediamine-tetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clinical Infectious Diseases 2003;36:116-9.
13. Chatzinikolaou 2003 Chatzinilolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, et al.Antibiotic coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective randomized study. American Journal of Medicine 2003;115:352-7.
14. Dawson 2000 Dawson S, Fitzgerald P, Langer JC, Walton M, Winthrop A, Lau G, et al.A preoperative protocol for the prevention of infection in children with tunnelled right atrial catheters. Oncology Repertorium 2000;7:1239-42.
15. Fourcade 2001 Fourcade J, Mallaval FO, Raffenot D, Mercier D, Maret J, Morel B. Value of an antibiotic lock for the prevention of bacteraemia recurrence from central catheters in chronic hemodialysis. Nephrologie 2001;22(8):457-8.
16. Garland 2005 Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution for the prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective randomized trial. Pediatrics 2005;116:198-205.
17. Hanna 2004 Hanna H, Benjamin R, Chatzinikolaou I, Alakech B, Richardson D, Mansfield P, et al.Long-termsilicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. Journal of Clinical Oncology 2004;22(15):3163-71.
18. Ocete 1998 Ocete E, Ruiz-Extremera A, Goicoechea A, Lozano E, Robles C, Rey ML, et al.Low dosage prophylactic vancomycin in central venous catheters for neonates. Early Human Development 1998;Suppl 53:S181-6.
19. Raad 1998 Raad II, Hachem RY, Abi-Said D, Rolston KV, Whimbey E, Buzaid AC, et al.A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin 2. Cancer 1998;82(2):403- 11.
20. Rubie 1995 Rubie H, Juricic M, Claeyssens S, Krimou A, Lemozy J, Izard P, et al.Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer. Archives of Diseases in Childhood 1995;72:325-9.
21. Abbas 2004 Abbas AA, Fryer CJ, Paltiel C, Chedid F, Felimban SK, Yousef AA, et al.Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatric Blood and Cancer 2004;42:325-31.
22. Bagnall-Reeb 2004 Bagnall-Reeb H. Evidence for the use of the antibiotic lock technique. Journal of Infusion Nursing 2004;27(2):118-22.
23. CPAC 1990 Hospital Infection Control Practices Advisory Committee. Recommendations for the prevention of nosocomial intravascular device related infections. American Journal of Infection Control 1990;24(4):277- 93.
24. Darouiche 1999 Darouiche RO. Prevention of vascular catheter related infections. The Netherlands Journal of Medicine 1999;55:92-9.
25. Donowitz 2001 Donowitz G, Maki D, Crnich J, Pappas P, Rolston K. Infections in the neutropenic patient-new views of an old problem. Hematology 2001:113-39.
26. Groeger 1993 Groeger JS, Lucas AB, Coit D, LaQuaglia M, Brown AE, Turnbull A, et al.A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Annals of Surgery 1993;91:3.
27. Hachem 2002 Hachem R, Raad I. Prevention andmanagement of longterm catheter related infections in cancer patients. Cancer Investigation 2002;20(7 and 8):1105-1113.
28. Ingram 1991 Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external catheters and subcutaneous ports. American Journal of Pediatric Hematology and Oncology 1991;13:130-6.
29. Mermel 2001 Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, et al.Guidelines for the management of Intravascular catheter-related infections. Clinical Infectious Diseases 2001;32:1249-72.
30. O'Grady 2002 O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al.Guidelines for the prevention of intravascular catheter related infections. Pediatrics 2002;110:51-75.
31. Press 1984 Press OW, Ramsey PG, Larson EB. Hickman catheter infections in patients with malignancies. Medicine 1984;63:189.
32. Salzman 1995 Salzman M, Rubin L. Intravenous catheter-related infections. Advances in Pediatric Infectious Diseases 1995;10:337-68.
33. Sarper 2006 Sarper N, Zengin E, Corapcioglu F, Tugay M. Totally implantable central venous access devices in children with hemato oncologic malignancies: Evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices. Pediatric Hematology and Oncology 2006;23:459-70.
34. Schinabeck 2003 Schinabeck MK, Ghannoum MA. Catheter related infections-diagnosis treatment and prevention. Clinical Microbiology Newsletter 2003;25(15):113-9.
35. Shaul 1998 Shaul DB, Scheer B, Rokhsar S, Jones VA, Chan LS, Boody BA, et al.Risk factors for early infection of central venous catheters in pediatric patients. Journal of the American College of Surgeons 1998;186(6):654-8.
36. Simon 2006 Simon A, Bode U, Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clinical Microbiology and Infection 2006;12:606-20.
37. van Tulder 1997 van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back review group for spinal disorders. Spine 1997;22:2323-30.
38. van de Wetering 2005 van de Wetering MD, van Woensel JB, Kremer LC, Caron HN. Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. Cancer Treatment Review 2005;3:186-96.